EZZ Life Science Holdings (ASX:EZZ) EBITDA Margin % : 7.98% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. EZZ Life Science Holdings's EBITDA for the six months ended in Dec. 2023 was A$1.73 Mil. EZZ Life Science Holdings's Revenue for the six months ended in Dec. 2023 was A$21.70 Mil. Therefore, EZZ Life Science Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was 7.98%.

EZZ Life Science Holdings EBITDA Margin % Historical Data

The historical data trend for EZZ Life Science Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings EBITDA Margin % Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

EBITDA Margin %

12.89

12.67

13.71

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial			2.83	19.60	12.16	14.78	7.98

Competitive Comparison of EZZ Life Science Holdings's EBITDA Margin %

For the Biotechnology subindustry, EZZ Life Science Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EZZ Life Science Holdings's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's EBITDA Margin % falls into.

EZZ Life Science Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

EZZ Life Science Holdings's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	5.093	/	37.143
	=	13.71 %

EZZ Life Science Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1.732	/	21.697
	=	7.98 %

EZZ Life Science Holdings (ASX:EZZ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

EZZ Life Science Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines